Open AccessFavipiravir and the Need for Early Ambulatory Treatment of COVID-19
Author(s) -
Tony M. Korman
Publication year - 2020
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.02489-20
Subject(s) - favipiravir , covid-19 , pandemic , ambulatory , medicine , randomized controlled trial , intensive care medicine , limiting , gold standard (test) , disease , virology , outbreak , infectious disease (medical specialty) , mechanical engineering , engineering
The commentary by McCullough emphasizes the urgent need for early ambulatory therapy of COVID-19 (1).….
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom